AeroRx Therapeutics, Inc. — Form D

AeroRx Therapeutics, Inc. of LA JOLLA, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-10-10. The offering totals $20.8M, of which $10.4M was reported sold. Industry: Other Health Care.

Offering

• Filed: 2025-10-10
• Form: D
• Accession: 0001231919-25-000297
• Industry: Other Health Care
• Exemptions: 06b
• Total offering: $20.8M
• Amount sold: $10.4M
• Remaining: $10.4M
• Investors: 17
• Date of first sale: 2025-09-25
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-560436

Issuer

• Name: AeroRx Therapeutics, Inc.
• CIK: 0002090778
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2024
• Address: 11099 NORTH TORREY PINES RD, SUITE 290, LA JOLLA, CA, 92037
• Phone: 858-869-5635

Officers, directors & promoters (7)

More

• CIK 2090778 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search